Joel Latham

Industry Briefing: Medicinal Harvest, Cannasouth/Eqalis, Cann Group, MGC Pharma, Incannex, Neurotech

Finance

Industry Briefing: Medicinal Harvest, Cannasouth/Eqalis, Cann Group, MGC Pharma, Incannex, Neurotech

May 03, 2023

Industry Updates: Helius Therapeutics, Little Green Pharma, MGC Pharma, Incannex

Medical

Industry Updates: Helius Therapeutics, Little Green Pharma, MGC Pharma, Incannex

December 07, 2022

Incannex raises A$13m from global investors as shares drop nearly 11%

Finance

Incannex raises A$13m from global investors as shares drop nearly 11%

December 05, 2022

Industry Roundup: Bod Australia, Incannex, Medlab, Rua Bioscience, Emyria

Medical

Industry Roundup: Bod Australia, Incannex, Medlab, Rua Bioscience, Emyria

October 20, 2022

Incannex receives ethics approval for phase one clinical trial of CBD-based anti-inflammatory drug

Medical

Incannex receives ethics approval for phase one clinical trial of CBD-based anti-inflammatory drug

July 22, 2022

Dr Sud Argawal steps down from Incannex board

Medical

Dr Sud Argawal steps down from Incannex board

June 28, 2022

Incannex progresses APIRx acquisition

Finance

Incannex progresses APIRx acquisition

May 13, 2022

Company news: Medigrowth; Greenfern Industries; Incannex; Cannatrek; MediPharm Labs; Cresco Labs

Finance

Company news: Medigrowth; Greenfern Industries; Incannex; Cannatrek; MediPharm Labs; Cresco Labs

March 24, 2022

Recent developments from Emyria, Incannex, Epsilon, and AusCann

Finance

Recent developments from Emyria, Incannex, Epsilon, and AusCann

March 08, 2022

Updates from Eight Cannabis-Focused Companies: Financial Results and Clinical Progress

Finance

Updates from Eight Cannabis-Focused Companies: Financial Results and Clinical Progress

March 03, 2022